GlassScriptPhysician profile
Jimmy N Ponder
NPI 1689644874
$1,921.99
in general payments reported to CMS, 2019-2025
27 companies · $392 in 2025
The $392 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $197 · 2020: $79.67 · 2021: $586 · 2022: $141 · 2023: $235 · 2024: $291 · 2025: $392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $917.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $413.48 | 2021-2025 | Intracept |
| Abbvie INC. | $289.20 | 2021-2025 | |
| Abbott Laboratories | $207.70 | 2019-2024 | Eterna |
| Pfizer INC. | $151.76 | 2024-2025 | |
| Saluda Medical Americas, INC. | $136.04 | 2023 | Evoke Scs |
| Vertos Medical, INC. | $118.36 | 2024 | Mild Device Kit |
| Nevro Corp. | $103.36 | 2019-2024 | Senza |
| Stryker Corporation | $89.92 | 2025 | Multigen 2, Mild Device Kit |
| Medtronic, INC. | $59.32 | 2021 | |
| Stimwave Technologies Incorporated | $51.00 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $42.80 | 2019-2020 | |
| Bioventus LLC | $30.97 | 2019 | |
| Relievant Medsystems, INC. | $24.96 | 2021 | |
| Zyla Life Sciences, INC. | $17.71 | 2019 | |
| Impel Pharmaceuticals INC. | $17.21 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $17.21 | 2025 | Ha Minuteman G3-R |
| Grt US Holding, INC. | $16.30 | 2021 | |
| Vertiflex, INC. | $15.81 | 2019 | |
| Acacia Pharma INC | $15.49 | 2021 | |
| Lundbeck LLC | $15.01 | 2022 | |
| Lilly USA, LLC | $14.14 | 2021 | |
| Allergan, INC. | $13.87 | 2020 | |
| Almatica Pharma LLC | $13.26 | 2021 | |
| Arbor Pharmaceuticals, INC. | $12.21 | 2021 | |
| Medtronic USA, INC. | $12.20 | 2020 | |
| Nalu Medical, INC. | $11.48 | 2021 | |
| Pacira Therapeutics, INC. | $11.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jimmy Ponder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.